These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13169361)

  • 1. [Drug therapy of arterial hypertension; pentapyrrolidinium bitartrate (ansolysen), a new remedy for peroral use].
    RØNNOV-JESSEN V
    Ugeskr Laeger; 1954 Apr; 116(15):551-8. PubMed ID: 13169361
    [No Abstract]   [Full Text] [Related]  

  • 2. Reserpine, alone & combined with pentapyrrolidine bitartrate (ansolysen), in prolonged ambulatory therapy of arterial hypertension.
    FLACHS A; FRANTZEN A; ROJEL J
    Ugeskr Laeger; 1957 Oct; 119(40):1306-10. PubMed ID: 13496331
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of pyrroplegium bitartrate (ansolysen) on arterial hypertension; study of 27 cases].
    JOLY F; BRIAL E
    Presse Med (1893); 1958 Sep; 66(63):1415-8. PubMed ID: 13591268
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience in the treatment of hypertension with pentapyrrolidinium (ansolysen) in a hypertension outpatient clinic.
    POMERANTZ HZ; BARSKY S; GORDON L; WENER J
    Can Med Assoc J; 1957 Aug; 77(4):325-8. PubMed ID: 13446819
    [No Abstract]   [Full Text] [Related]  

  • 5. Pentapyrrolidinium bitartrate (M. & B. 2050A) in the treatment of hypertension; preliminary observations.
    GIFFORD RW; ALLEN EV; BIRKHEAD NC
    Proc Staff Meet Mayo Clin; 1954 Sep; 29(18):496-508. PubMed ID: 13204389
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pentapyrrolidinium (ansolysen) therapy of hypertension].
    PERSSON I
    Ugeskr Laeger; 1954 Nov; 116(45):1601-3. PubMed ID: 13226509
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pentapyrrolidinium (ansolysen) therapy of malignant hypertension].
    VAN DER STRAETEN M
    Belg Tijdschr Geneesk; 1955 Aug; 11(15):759-67. PubMed ID: 13249936
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of arterial hypertension with M & B 2050A (pentapyrrolidinium bitartrate)].
    FERNANDEZ FERRER O; MACIAS CASTRO I; LOPEZ DE LA VEGA R
    Arch Hosp Univ; 1955; 7(2):113-9. PubMed ID: 13269266
    [No Abstract]   [Full Text] [Related]  

  • 9. [Decrease in blood pressure after parenteral trial doses of reserpine (serpasil), hydralazine (apresolin), and pentapyrrolidin (ansolysen) in patients with arterial hypertension, with special reference to the value of the test as an indicator of the clinical effect in subsequent peroral prolonged treatment].
    KJERULF-JENSEN K; STURUP H
    Ugeskr Laeger; 1956 Oct; 118(40):1166-7. PubMed ID: 13392090
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pentapyrrolidinium tartrate in arterial hypertension].
    MERLI A; MUSCARI A
    Minerva Med; 1957 Sep; 48(78):3140-5. PubMed ID: 13483343
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of hypertension with pentapyrrolidinium.
    KAINDL F; RUMMELHARDT K
    Wien Z Inn Med; 1956 Nov; 37(11):465-70. PubMed ID: 13401791
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of hypertension by the ganglion blocking agents, oxaditon & ansolysen].
    CLAUSEN JP
    Ugeskr Laeger; 1957 Oct; 119(40):1310-3. PubMed ID: 13496332
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal haemodynamic effects of hypotensive drugs. II. Effects of oral maintenance therapy with pentapyrrolidinium bitartrate and reserpine.
    GOLDBERG B; MCDONALD L
    Lancet; 1957 Jan; 272(6959):77-8. PubMed ID: 13386279
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of effects on hypertension of hexamethonium and pentapyrrolidinium injected subcutaneously.
    BIRKHEAD NC; ALLEN EV
    Proc Staff Meet Mayo Clin; 1954 Sep; 29(18):489-96. PubMed ID: 13204388
    [No Abstract]   [Full Text] [Related]  

  • 15. Ansolysen in the treatment of arterial hypertension.
    DAVIGNON A; LEMIEUX G; GENEST J
    Can Med Assoc J; 1956 May; 74(10):802-7. PubMed ID: 13316673
    [No Abstract]   [Full Text] [Related]  

  • 16. [Peroral therapy of hypertension with hexamethonium compounds].
    ERLSBACHER O; GAISBERGER H
    Wien Med Wochenschr; 1955 Jan; 105(3):64-6. PubMed ID: 14359994
    [No Abstract]   [Full Text] [Related]  

  • 17. [Peroral combination therapy of hypertension].
    BIRKMAYER W; LANGNER E
    Wien Med Wochenschr; 1957 Feb; 107(7):161-2. PubMed ID: 13423303
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hypertension with hexamethonium salts and pentamethylene 1,5-bis(1-methylpyrrolidinium)-bitartrate].
    SMIRK FH
    Athena; 1954; 20(6-7):243-8. PubMed ID: 13198761
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of hypertension with 3-methyl-pentapyrrolidinium].
    MOELLER J
    Med Klin; 1956 Aug; 51(35):1466-71. PubMed ID: 13358552
    [No Abstract]   [Full Text] [Related]  

  • 20. Practical details of the treatment of hypertension by hexamethonium salts and by pentamethylene 1:5-bis-N-(N-methylpyrrolidinium) bitartrate (M. & B. 2050A).
    SMIRK FH
    N Z Med J; 1953 Oct; 52(291):325-48. PubMed ID: 13119920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.